Common Metabolic Enzyme Could Predict Cancer Immunotherapy Benefits — and Help More Patients Respond
In a Rutgers study, mice given a two-drug combination survived at far higher rates, suggesting a strategy that could improve the effectiveness of some cancer immunotherapies.